6JU-29248-08513 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-25
Dose 1 — Pfizer-BioNTech
2021-03-22
Registered in v-safe
2021-03-22
Dose 2 — Pfizer-BioNTech
2021-03-22
Survey response — day 0, dose 2
MedDRA: Unevaluable event — Feeling: Good

Free text: Chemotherapy starting mid to late April 2021.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-25
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-29
Health check-in — day 7, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-04-05
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-04-12
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-19
Survey response — day 28, dose 2
MedDRA: Hilar lymphadenopathy, Lymphadenopathy, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: PET scan F-18 FDG IV. April 08,2021. Mildly hyper metabolic bilayeryhilar as well as portacaval retropenitoneal lymph nodes and right axillary lymph nodes. Indeterminate for benign reactive adenopathy versus nascent lymphatic metastases. · Healthcare visit (other): Oncologist and pulmonologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-19
Report sent to call center — day 28, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-27
Survey response — day 35, dose 2
MedDRA: Adverse reaction, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: PET scan F-18 FDG IV. 04-08-2021. Mildly hyper metabolic bilayeryhilar as well as portacaval retropenitoneal lymph nodes and right axillary lymph nodes.04/21/2021 Chemotherapy port..Future:04/29/202 Bronscopy biopsy of lymph nodes/nodule. · Healthcare visit (other): Pulmonary onocolgist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Report sent to call center — day 35, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-03
Survey response — day 42, dose 2
MedDRA: Chest discomfort, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Chest discomfort. Chest discomfort Bronchoscopy April 29, 2021 for positive PET scan of chest. Biopsy of lymph node and nodules taken. Reports pending. · Healthcare visit (other): Pulmonologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-03
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-11-05
Dose 3 — Pfizer-BioNTech
2022-02-28
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-25	Pfizer-BioNTech
2	2021-03-22	Pfizer-BioNTech
3	2021-11-05	Pfizer-BioNTech	No

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 6 — day 0, dose 2

2021-03-22

Systemic reaction (other): Chemotherapy starting mid to late April 2021.

Release 7 — day 28, dose 2

2021-04-19

Symptoms: PET scan F-18 FDG IV. April 08,2021. Mildly hyper metabolic bilayeryhilar as well as portacaval retropenitoneal lymph nodes and right axillary lymph nodes. Indeterminate for benign reactive adenopathy versus nascent lymphatic metastases.

Healthcare visit (other): Oncologist and pulmonologist

Release 8 — day 35, dose 2

2021-04-27

Symptoms: PET scan F-18 FDG IV. 04-08-2021. Mildly hyper metabolic bilayeryhilar as well as portacaval retropenitoneal lymph nodes and right axillary lymph nodes.04/21/2021 Chemotherapy port..Future:04/29/202 Bronscopy biopsy of lymph nodes/nodule.

Healthcare visit (other): Pulmonary onocolgist

Release 8 — day 42, dose 2

2021-05-03

Symptoms: Chest discomfort. Chest discomfort Bronchoscopy April 29, 2021 for positive PET scan of chest. Biopsy of lymph node and nodules taken. Reports pending.

Healthcare visit (other): Pulmonologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	Adverse reaction	✓	✓	✓
SD	Chest discomfort	✓	✓	✓
SD	Hilar lymphadenopathy	○	✓	○
SD	Lymphadenopathy	✓	✓	✓
SRO	Unevaluable event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release